Table 4.
Metabolites associated with FEV1/FVC at FDR < 0.05 in meta-analysis *.
Meta-Analysis | ARIC African Ancestry (n = 2354) |
ARIC European Ancestry (n = 1529) |
KORA (n = 859) |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Metabolite | Super Pathway | Beta + | SE | P | Direction ** | Beta | SE | P | Beta | SE | P | Beta | SE | P |
3-methoxytyrosine | Amino Acid | −0.42 | 0.10 | 5.0 × 10−5 | −−− | −0.37 | 0.13 | 4.1 × 10−3 | −0.45 | 0.35 | 2.0 × 10−1 | −0.53 | 0.20 | 8.1 × 10−3 |
androsterone sulfate | Lipid | 0.37 | 0.10 | 2.5 × 10−4 | +++ | 0.29 | 0.16 | 7.9 × 10−2 | 0.31 | 0.17 | 7.0 × 10−2 | 0.57 | 0.20 | 5.6 × 10−3 |
glycerol | Lipid | −0.36 | 0.11 | 8.6 × 10−4 | −−− | −0.27 | 0.16 | 9.1 × 10−2 | −0.52 | 0.20 | 7.4 × 10−3 | −0.32 | 0.22 | 1.4 × 10−1 |
dehydroisoandrosterone sulfate (DHEA-S) | Lipid | 0.35 | 0.11 | 1.2 × 10−3 | +++ | 0.39 | 0.17 | 2.1 × 10−2 | 0.37 | 0.19 | 5.1 × 10−2 | 0.27 | 0.22 | 2.2 × 10−1 |
lathosterol | Lipid | 0.34 | 0.10 | 7.4 × 10−4 | +++ | 0.38 | 0.15 | 1.3 × 10−2 | 0.37 | 0.18 | 4.1 × 10−2 | 0.24 | 0.20 | 2.5 × 10−1 |
oleoylcarnitine | Lipid | −0.42 | 0.10 | 2.9 × 10−5 | −−− | −0.46 | 0.15 | 2.1 × 10−3 | −0.50 | 0.18 | 4.8 × 10−3 | −0.23 | 0.20 | 2.7 × 10−1 |
7-alpha-hydroxy-3-oxo-4-cholestenoate (7-Hoca) | Lipid | −0.33 | 0.10 | 9.6 × 10−4 | −−− | −0.32 | 0.16 | 3.8 × 10−2 | −0.28 | 0.17 | 1.1 × 10−1 | −0.42 | 0.21 | 4.0 × 10−2 |
theophylline | Xenobiotics | −0.62 | 0.10 | 4.0 × 10−10 | −−− | −0.72 | 0.14 | 4.8 × 10−7 | −0.73 | 0.18 | 7.5 × 10−5 | −0.26 | 0.21 | 2.1 × 10−1 |
* Metabolites measured in all three populations were shown in this table. All metabolites associations with FEV1/FVC were shown in Supplementary Table S6. + Regression coefficient: difference in FEV1/FVC (scaled as a percentage) per SD change in the metabolite levels. ** Direction of effect: the first, second and third +, or − refers to the direction of effect in ARIC African ancestry, ARIC European ancestry and KORA.